UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
10-Q
(MARK
ONE)
☒ QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For
the quarter ended September 30, 2021
☐ TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For
the transition period from to
Commission
file number: 001-40058
ROSECLIFF
ACQUISITION CORP I
(Exact
Name of Registrant as Specified in Its Charter)
Delaware 85-3987148
(State or other jurisdiction of
incorporation or organization) (I.R.S. Employer
Identification No.)
767
5th Avenue 34th Floor
New
York , New York 10153
(Address
of principal executive offices)
(212)
492-3000
(Issuer’s
telephone number)
Securities
registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant RCLFU The Nasdaq Stock Market LLC
Class A common stock, par value $0.0001 per share RCLF The Nasdaq Stock Market LLC
Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 RCLFW The Nasdaq Stock Market LLC
Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such
reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No
☐
Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files). Yes ☒ No ☐
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller
reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer ☒ Smaller reporting company ☒
Emerging growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐
As
of November 22, 2021, there were 25,300,000 shares of Class A common stock, $0.0001 par
value and 6,325,000 shares of Class B common stock, $0.0001 par value, issued and outstanding.
ROSECLIFF
ACQUISITION CORP I
FORM
10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2021
TABLE
OF CONTENTS
Page
Part I. Financial Information
Item 1. Financial Statements
1
Condensed Balance Sheets as of September 30, 2021 (Unaudited) and December 31, 2020
1
Unaudited Condensed Statements of Operations for the three and nine months ended September 30, 2021
2
Unaudited Condensed Statement of Changes in Stockholders’ (Deficit) Equity for the three and nine months ended September 30, 2021
3
Unaudited Condensed Statement of Cash Flows for the nine months ended September 30, 2021
4
Notes to Condensed Financial Statements (Unaudited)
5
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
23
Item 3. Quantitative and Qualitative Disclosures Regarding Market Risk
26
Item 4. Controls and Procedures
26
Part II. Other Information
Item 1. Legal Proceedings
27
Item 1A. Risk Factors
27
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
28
Item 3. Defaults Upon Senior Securities
28
Item 4. Mine Safety Disclosures
28
Item 5. Other Information
28
Item 6. Exhibits
29
Part III. Signatures
30
i
PART
I - FINANCIAL INFORMATION
Item
1. Interim Financial Statements.
ROSECLIFF
ACQUISITION CORP I
CONDENSED
BALANCE SHEETS
September 30,
2021
December 31,
2020
(Unaudited)
ASSETS
Current assets
Cash
$ 863,774
$ —
Prepaid expenses
399,038
—
Total Current Assets
1,262,812
—
Deferred offering costs
—
164,899
Marketable securities held in Trust Account
253,023,010
—
TOTAL ASSETS
$ 254,285,822
$ 164,899
LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY
Current liabilities
Accrued expenses
$ 1,306,051
$ 675
Accrued offering costs
12,000
99,899
Due to Sponsor
16,152
—
Promissory note – related party
—
40,000
Total Current Liabilities
1,334,203
140,574
Warrant liabilities
7,227,000
—
Deferred underwriting fee payable
8,855,000
—
Total Liabilities
17,416,203
140,574
Commitments and contingencies
Class A common stock subject to possible redemption 25,300,000 and no shares at $ 10.00 per share redemption value at September 30, 2021 and December 31, 2020, respectively
253,000,000
—
Stockholders’ (Deficit) Equity
Preferred stock, $ 0.0001 par value; 1,000,000 shares authorized; none issued or outstanding
—
—
Class A common stock, $ 0.0001 par value; 80,000,000 shares authorized
—
—
Class B common stock, $ 0.0001 par value; 20,000,000 shares authorized; 6,325,000 shares issued and outstanding at September 30, 2021 and December 31, 2020 (1)(2)
633
633
Additional paid-in capital
—
24,367
Accumulated deficit
( 16,131,014 )
( 675 )
Total Stockholders’ (Deficit) Equity
( 16,130,381 )
24,325
TOTAL LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY
$ 254,285,822
$ 164,899
(1) At December 31, 2020, included up to 825,000 shares subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters (see Note 6).
(2) On February 11, 2021, the Company effected a 1:1.1 stock split
of its Class B common stock, resulting in an aggregate of 6,325,000 shares outstanding. All share and per-share amounts have been retroactively
restated to reflect the stock split.
The
accompanying notes are an integral part of the unaudited condensed financial statements.
1
ROSECLIFF
ACQUISITION CORP I
CONDENSED
STATEMENTS OF OPERATIONS
(UNAUDITED)
Three Months
Ended
September 30,
Nine Months
Ended
September 30,
2021
2021
General and administrative expenses
$ 1,192,736
$ 1,637,589
Loss from operations
( 1,192,736 )
( 1,637,589 )
Other income (expense):
Change in fair value of warrants
3,416,400
4,599,000
Transaction costs allocated to warrant liabilities
—
( 438,283 )
Interest earned on marketable securities held in Trust Account
3,506
23,010
Total other income (expense), net
3,419,906
4,183,727
Net income
$ 2,227,170
$ 2,546,138
Weighted average shares outstanding, Class A common stock
25,300,000
20,851,648
Basic and diluted net income per share, Class A common stock
$ 0.07
$ 0.09
Weighted average shares outstanding, Class B common stock
6,325,000
6,179,945
Basic and diluted net income per share, Class B common stock
$ 0.07
$ 0.09
The
accompanying notes are an integral part of the unaudited condensed financial statements.
2
ROSECLIFF
ACQUISITION CORP I
CONDENSED
STATEMENTS OF CHANGES IN STOCKHOLDERS’ (DEFICIT) EQUITY
THREE
AND NINE MONTHS ENDED SEPTEMBER 30, 2021
(UNAUDITED)
Class
A
Common Stock
Class
B
Common Stock
Additional
Paid-in
Accumulated
Total
Stockholders’
Equity
Shares
Amount
Shares
Amount
Capital
Deficit
(Deficit)
Balance
— January 1, 2021
—
$ —
6,325,000
$ 633
$ 24,367
$ ( 675 )
$ 24,325
Cash
paid in excess of fair value of Private placement warrants
—
—
—
—
2,824,000
—
2,824,000
Accretion
for Class A ordinary shares to redemption amount
—
—
—
—
( 2,848,367 )
( 18,676,477 )
( 21,524,844 )
Net
income
—
—
—
—
—
3,221,641
3,221,641
Balance
– March 31, 2021 (unaudited) (as restated)
—
$ —
6,325,000
$ 633
$ —
$ ( 15,455,511 )
$ ( 15,454,878 )
Net
loss
—
—
—
—
—
( 2,902,673 )
( 2,902,673 )
Balance
– June 30, 2021 (unaudited) (as restated)
—
$ —
6,325,000
$ 633
$ —
$ ( 18,358,184 )
$ ( 18,357,551 )
Net
income
—
—
—
—
—
2,227,170
2,227,170
Balance
– September 30, 2021 (unaudited)
—
$ —
6,325,000
$ 633
$ —
$ ( 16,131,014 )
$ ( 16,130,381 )
The
accompanying notes are an integral part of the unaudited condensed financial statements.
3
ROSECLIFF
ACQUISITION CORP I
CONDENSED
STATEMENT OF CASH FLOWS
NINE
MONTHS ENDED SEPTEMBER 30, 2021
(UNAUDITED)
Cash Flows from Operating Activities:
Net income
$ 2,546,138
Adjustments to reconcile net loss to net cash used in operating activities:
Change in fair value of warrant liabilities
( 4,599,000 )
Transaction costs allocated to warrant liabilities
438,283
Interest earned on marketable securities held in Trust Account
( 23,010 )
Changes in operating assets and liabilities:
Prepaid expenses
( 399,038 )
Accrued expenses
1,305,376
Net cash used in operating activities
( 731,251 )
Cash Flows from Investing Activities:
Investment of cash in Trust Account
( 253,000,000 )
Net cash used in investing activities
( 253,000,000 )
Cash Flows from Financing Activities:
Proceeds from sale of Units, net of underwriting discounts paid
247,940,000
Proceeds from sale of Private Placements Warrants
7,060,000
Proceeds from promissory note – related party
109,152
Repayments of promissory note – related party
( 133,000 )
Payment of offering costs
( 381,127 )
Net cash provided by financing activities
254,595,025
Net Change in Cash
863,774
Cash – Beginning of period
—
Cash – End of period
$ 863,774
Non-Cash investing and financing activities:
Offering costs included in accrued offering costs
$ 12,000
Payment of accrued expenses through promissory note
16,152
Deferred underwriting fee payable
$ 8,855,000
The
accompanying notes are an integral part of the unaudited condensed financial statements.
4
ROSECLIFF
ACQUISITION CORP I
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2021
(Unaudited)
NOTE
1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Rosecliff
Acquisition Corp I (the “Company”) is a blank check company incorporated in Delaware on November 17, 2020. The Company was
formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business
combination with one or more businesses (the “Business Combination”).
The
Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early
stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth
companies.
As
of September 30, 2021, the Company had not commenced any operations. All activity for the period from November 17, 2020 (inception) through
September 30, 2021 relates to the Company’s formation and the initial public offering (“Initial Public Offering”),
which is described below, and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The
Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The
Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering.
The Company has selected December 31 as its fiscal year end.
The
registration statement for the Company’s Initial Public Offering was declared effective on February 11, 2021. On February 17, 2021
the Company consummated the Initial Public Offering of 25,300,000 units (the “Units” and, with respect to the Class A common
stock included in the Units sold, the “Public Shares”), which includes the full exercise by the underwriter of its over-allotment
option in the amount of 3,300,000 Units, at $ 10.00 per Unit, generating gross proceeds of $ 253,000,000 , which is described in Note 4.
Simultaneously
with the closing of the Initial Public Offering, the Company consummated the sale of 4,706,667 warrants (the “Private Placement
Warrants”) at a price of $ 1.50 per Private Placement Warrant in a private placement to Rosecliff Acquisition Sponsor I LLC (the
“Sponsor”) generating gross proceeds of $ 7,060,000 , which is described in Note 5.
Transaction
costs amounted to $ 14,373,127 , consisting of $ 5,060,000 in cash underwriting fees, $ 8,855,000 in deferred underwriting fees, and $ 458,127
of other offering costs.
Following
the closing of the Initial Public Offering on February 17, 2021, an amount of $ 253,000,000 ($ 10.00 per Unit) from the net proceeds
of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account
(the “Trust Account”), located in the United States and was invested only in U.S. government securities, within the
meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940 (the “Investment Company Act”), with a maturity of
185 days or less or in money market funds meeting certain conditions under Rule 2a-7 of the Investment Company Act, which
invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the
completion of a Business Combination and (ii) the distribution of the funds held in the Trust Account, as described
below.
The
Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering
and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward
consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully.
The Company must complete one or more initial Business Combinations with one or more operating businesses or assets that together have
a fair market value equal to at least 80 % of the assets held in the Trust Account (as defined below) (excluding any deferred underwriting
commissions and taxes payable on the income earned on the Trust Account). The Company will only complete a Business Combination if the
post-transaction company owns or acquires 50 % or more of the outstanding voting securities of the target or otherwise acquires a controlling
interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company
Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to complete a
Business Combination successfully.
5
ROSECLIFF
ACQUISITION CORP I
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2021
(Unaudited)
The
Company will provide the holders of the outstanding Public Shares (the “Public Stockholders”) with the opportunity to redeem
all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder
meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will
seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Stockholders will
be entitled to redeem their Public Shares for a pro rata portion of the amount then held in the Trust Account (initially $ 10.00 per Public
Share, plus any pro rata interest then in the Trust Account, net of taxes payable). There will be no redemption rights upon the completion
of a Business Combination with respect to the Company’s warrants.
The
Company will only proceed with a Business Combination if the Company has net tangible assets of at least $ 5,000,001 following any related
redemptions and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business Combination.
If a stockholder vote is not required by applicable law or stock exchange listing requirements and the Company does not decide to hold
a stockholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation
(the “Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and
Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If,
however, stockholder approval of the transaction is required by applicable law or stock exchange listing requirements, or the Company
decides to obtain stockholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy
solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection
with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 6) and any Public Shares purchased
during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each Public Stockholder may elect
to redeem their Public Shares without voting, and if they do vote, irrespective of whether they vote for or against the proposed transaction.
Notwithstanding
the foregoing, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the
tender offer rules, the Certificate of Incorporation will provide that a Public Stockholder, together with any affiliate of such stockholder
or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of
the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with
respect to more than an aggregate of 15 % of the Public Shares, without the prior consent of the Company.
The
Sponsor has agreed (a) to waive its redemption rights with respect to the Founder Shares and Public Shares held by it in connection
with the completion of a Business Combination and (b) not to propose an amendment to the Certificate of Incorporation (i) to
modify the substance or timing of the Company’s obligation to allow redemptions in connection with a Business Combination or to
redeem 100 % of its Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below)
or (ii) with respect to any other provision relating to stockholders’ rights or pre-business combination activity, unless
the Company provides the Public Stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.
The
Company will have until February 17, 2023 to complete a Business Combination (the “Combination Period”). If the Company has
not completed a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose
of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares,
at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned
on the funds held in the Trust Account and not previously released to pay taxes (less up to $ 100,000 of interest to pay dissolution expenses),
divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Stockholders’ rights
as stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably
possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board
of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims
of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect
to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination
Period.
6
ROSECLIFF
ACQUISITION CORP I
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2021
(Unaudited)
The
Sponsor has agreed to waive its rights to liquidating distributions from the Trust Account with respect to the Founder Shares it will
receive if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor or any of its
respective affiliates acquire Public Shares, such Public Shares will be entitled to liquidating distributions from the Trust Account
if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights
to their deferred underwriting commission (see Note 7) held in the Trust Account in the event the Company does not complete a Business
Combination within the Combination Period, and in such event, such amounts will be included with the other funds held in the Trust Account
that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share
value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($ 10.00 ).
In
order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims
by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed
entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share
and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if
less than $10.00 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability
will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to monies held
in the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering
against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover,
in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the
extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify
the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company’s independent
registered public accounting firm), prospective target businesses and other entities with which the Company does business, execute agreements
with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.
Liquidity and Capital Resources
As of September 30, 2021, we had cash of $ 863,774 . We intend to use
the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective
target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives
or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete
a Business Combination.
In order to fund working capital
deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor, or certain of our officers and
directors or their affiliates may, but are not obligated to, loan us funds as may be required (the “Working Capital
Loans”). If we complete a Business Combination, we would repay such loaned amounts. In the event that a Business Combination
does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts, but no
proceeds from our Trust Account would be used for such repayment. Up to $ 1,500,000 of the Working Capital Loans may be convertible
into warrants of the post-Business Combination entity at a price of $ 1.50 per warrant. The warrants would be identical to the
Private Placement Warrants.
We do not believe we will need to raise additional funds in order to
meet the expenditures required for operating our business. However, if our estimate of the costs of identifying a target business, undertaking
in-depth due diligence and negotiating a Business Combination are less than the actual amount necessary to do so, we may have insufficient
funds available to operate our business prior to our Business Combination. Moreover, we may need to obtain additional financing either
to complete our Business Combination or because we become obligated to redeem a significant number of our Public Shares upon consummation
of our Business Combination, in which case we may issue additional securities or incur debt in connection with such Business Combination.
Based on the above, management evaluated the
Company’s liquidity and financial condition and has determined that sufficient capital and access to capital exists to sustain
operations for at least one year from the date the financial statements were issued.
7
ROSECLIFF ACQUISITION CORP I
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2021
(Unaudited)
NOTE
2. RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS
In connection with the preparation of the
Company’s financial statements as of September 30, 2021, management identified errors made in its historical financial statements
where, at the closing of the Company’s Initial Public Offering, the Company improperly valued its Class A common stock subject to
possible redemption. The Company previously determined the Class A common stock subject to possible redemption to be equal to the redemption
value, while also taking into consideration that a redemption cannot result in net tangible assets being less than $ 5,000,001 . Upon review
of its financial statements for the period ended September 30, 2021, the Company reevaluated the classification of the Class A common
stock and determined that the Class A common stock issued during the Initial Public Offering and pursuant to the exercise of the underwriters’
overallotment can be redeemed or become redeemable subject to the occurrence of future events considered outside the Company’s control
under ASC 480-10-S99. Therefore, management concluded that the carrying value should include all shares of Class A common stock subject
to possible redemption, resulting in the Class A common stock subject to possible redemption being classified as temporary equity in its
entirety. As a result, management has noted a reclassification error related to temporary equity and permanent equity. This resulted in
a restatement of the initial carrying value of the common stock subject to possible redemption with the offset recorded to additional
paid-in capital (to the extent available), accumulated deficit and common stock.
In accordance with SEC Staff
Accounting Bulletin No. 99, “Materiality,” and SEC Staff Accounting Bulletin No. 108, “Considering the Effects of Prior
Year Misstatements when Quantifying Misstatements in Current Year Financial Statements,” the Company evaluated the changes and
has determined that the related impact was material to previously presented financial statements and those previously issued financial
statements should no longer be relied upon. Therefore, the Company, in consultation with its Audit Committee, concluded that its previously
issued financial statements as of February 17, 2021, March 31, 2021 and June 30, 2021 should be restated to report all Public Shares
as temporary equity. As such the Company is reporting these restatements to those periods in this Quarterly Report.
In connection with the change in presentation
for the common stock subject to redemption, the Company also restated its income (loss) per common share calculated to allocate net income
(loss), with all allocated to common stock. This presentation contemplates a Business Combination as the most likely outcome, in which
case, both classes of common stock share pro rata in the income (loss) of the Company. There is no impact to the reported amounts for
total assets, total liabilities, or net income (loss).
8
ROSECLIFF ACQUISITION CORP I
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2021
(Unaudited)
The impact of the restatement on the Company’s financial
statements is reflected in the following tables:
Balance Sheet as of February 17, 2021 (audited)
As Previously
Reported
Adjustment
As Restated
Class A common stock subject to possible redemption
$ 228,885,190
$ 24,114,810
$ 253,000,000
Class A common stock
$ 241
$ ( 241 )
$ —
Additional paid-in capital
$ 5,438,092
$ ( 5,438,092 )
$ —
Accumulated deficit
$ ( 438,958 )
$ ( 18,676,477 )
$ ( 19,115,435 )
Total Stockholders’ Equity (Deficit)
$ 5,000,008
$ ( 24,114,810 )
$ ( 19,114,802 )
Balance Sheet as of March 31, 2021
Class A common stock subject to possible redemption
$ 232,545,120
$ 20,454,880
$ 253,000,000
Class A common stock
$ 205
$ ( 205 )
$ —
Additional paid-in capital
$ 1,778,198
$ ( 1,778,198 )
$ —
Accumulated deficit
$ 3,220,966
$ ( 18,676,477 )
$ ( 15,455,511 )
Total Stockholders’ Equity (Deficit)
$ 5,000,002
$ ( 20,454,880 )
$ ( 15,454,878 )
Balance Sheet as of June 30, 2021
Class A Common stock subject to possible redemption
$ 229,642,450
$ 23,357,550
$ 253,000,000
Class A Common stock
$ 234
$ ( 234 )
$ —
Additional paid-in capital
$ 4,680,839
$ ( 4,680,839 )
$ —
Accumulated deficit
$ 318,293
$ ( 18,676,477 )
$ ( 18,358,184 )
Total Shareholders’ Equity (Deficit)
$ 4,999,999
$ ( 23,357,550 )
$ ( 18,357,551 )
Statement of Operations
for the Three Months Ended March 31, 2021
As
Previously
Reported
Adjustment
As
Restated
Basic and diluted
weighted average shares outstanding, Class A common stock subject to possible redemption
25,300,000
( 25,300,000 )
—
Basic and diluted net income
(loss) per share, Class A common stock subject to possible redemption
$ —
$ —
$ —
Basic and diluted weighted
average shares outstanding, Non-redeemable common stock
5,885,000
( 5,885,000 )
—
Basic and diluted net income
(loss) per share, Non-redeemable common stock
$ 0.55
$ ( 0.55 )
$ —
Weighted average shares outstanding of Class
A common stock
—
11,939,326
11,939,326
Basic and diluted net income
per share, Class A common stock
$ —
$ 0.18
$ 0.18
Weighted average shares outstanding of Class
B common stock
—
5,885,000
5,885,000
Basic and diluted net income
per share, Class B common stock
$ —
$ 0.18
$ 0.18
Statement
of Operations for the Three Months Ended June 30, 2021
As Previously
Reported
Adjustment
As Restated
Basic and diluted weighted
average shares outstanding, Class A common stock subject to possible redemption
25,300,000
( 25,300,000 )
—
Basic and diluted net income
per share, Class A common stock subject to possible redemption
$ —
$ —
$ —
Basic and diluted weighted
average shares outstanding, Non-redeemable common stock
6,325,000
( 6,325,000 )
—
Basic and diluted net loss
(income) per share, Non-redeemable common stock
$ ( 0.46 )
$ 0.46
$ —
Weighted average shares outstanding of Class
A common stock
—
25,300,000
25,300,000
Basic and diluted net loss
per share, Class A common stock
$ —
$ ( 0.09 )
$ ( 0.09 )
Weighted average shares outstanding of Class
B common stock
—
6,325,000
6,325,000
Basic and diluted net loss
per share, Class B common stock
$ —
$ ( 0.09 )
$ ( 0.09 )
Statement
of Operations for the Six Months Ended June 30, 2021
As Previously
Reported
Adjustment
As
Restated
Basic and diluted weighted
average shares outstanding, Class A common stock subject to possible redemption
25,300,000
( 25,300,000 )
—
Basic and diluted net income
per share, Class A common stock subject to possible redemption
$ —
$ —
$ —
Basic and diluted weighted
average shares outstanding, Non-redeemable common stock
6,106,215
( 6,106,215 )
—
Basic and diluted net income
(loss) per share, Non-redeemable common stock
$ 0.05
$ ( 0.05 )
$ —
Weighted average shares outstanding of Class
A common stock
—
18,693,889
18,693,889
Basic and diluted net income
per share, Class A common stock
$ —
$ 0.01
$ 0.01
Weighted average shares outstanding of Class
B common stock
—
6,106,215
6,106,215
Basic and diluted net income
per share, Class B common stock
$ —
$ 0.01
$ 0.01
Statement
of Cash Flows for the Three Months Ended March 31, 2021 (Unaudited)
As Previously
Reported
Adjustment
As
Restated
Initial classification
of common stock subject to possible redemption
$ 228,885,190
$ 24,114,810
$ 253,000,000
Change in value of common
stock subject to redemption
$ 3,659,930
$ ( 3,659,930 )
$ —
Statement
of Cash Flows for the Six Months Ended June 30, 2021 (Unaudited)
As Previously
Reported
Adjustment
As
Restated
Initial classification
of common stock subject to possible redemption
$ 228,885,190
$ 24,114,810
$ 253,000,000
Change in value of common
stock subject to redemption
$ 757,250
$ ( 757,250 )
$ —
9
ROSECLIFF
ACQUISITION CORP I
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2021
(Unaudited)
NOTE
3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis
of Presentation
The
accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted
in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form
10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements
prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial
reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position,
results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include
all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating
results and cash flows for the periods presented.
The
accompanying unaudited condensed financial statements should be read in conjunction with the Company’s prospectus for its Initial
Public Offering as filed with the SEC on February 16, 2021. The interim results for the three and nine months ended September 30, 2021
are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any future periods.
Emerging
Growth Company
The
Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our
Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements
that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required
to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced
disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements
of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously
approved.
Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of
such extended transition period, which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company that
is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult
or impossible because of the potential differences in accounting standards used.
10
ROSECLIFF
ACQUISITION CORP I
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2021
(Unaudited)
Use
of Estimates
The
preparation of the condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and
assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date
of the financial statements and the reported amounts of revenues and expenses during the reporting period.
Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates
included in these financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject
to change as more current information becomes available and accordingly, the actual results could differ significantly from those estimates.
Cash
and Cash Equivalents
The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company did not have any cash equivalents as of September 30, 2021 and December 31, 2020.
Cash
and Marketable Securities Held in Trust Account
At
September 30, 2021, the majority of the assets held in the Trust Account were held in money market funds, which are invested
primarily in U.S. Treasury securities. At December 31, 2020, there were no assets held in the Trust Account. The Company presents
its investments in treasury securities on the balance sheet at amortized cost and adjusted for the amortization or accretion of
premiums or discounts. The Company presents its investments in money market funds on the balance sheet at fair value at the end of
each reporting period. Gains and losses resulting from the change in fair value of these securities are included in interest income
in the accompanying condensed statements of operations. The estimated fair value of investments held in the Trust Account is
determined using available market information.
Offering
Costs
Offering
costs consisted of legal, accounting and other expenses incurred through the Initial Public Offering that were directly related to the
Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based
on a relative fair value basis, compared to total proceeds received. Offering costs allocated to warrant liabilities were expensed as
incurred in the statements of operations. Offering costs associated with the Class A common stock issued were initially charged to temporary
equity and then accreted to common stock subject to redemption upon the completion of the Initial Public Offering.
Class
A Common Stock Subject to Possible Redemption
The
Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing
Liabilities from Equity.” Shares of Class A common stock subject to mandatory redemption are classified as a liability instrument
and are measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that features redemption
rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within
the Company’s control) is classified as temporary equity. At all other times, Class A common stock is classified as stockholders’
equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s
control and subject to occurrence of uncertain future events. Accordingly, at September 30, 2021 and December 31, 2020, 25,300,000 and
no Class A common stock subject to possible redemption is presented as temporary equity, respectively, outside of the stockholders’
equity section of the Company’s balance sheets.
11
ROSECLIFF
ACQUISITION CORP I
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2021
(Unaudited)
The
Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to
equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company
recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable Class A common
stock resulted in charges against additional paid-in capital and accumulated deficit.
At
September 30, 2021, the Class A common stock reflected in the condensed balance sheets are reconciled in the following table:
Gross proceeds
$ 253,000,000
Less:
Proceeds allocated to Public Warrants
$ ( 7,590,000 )
Class A common stock issuance costs
$ ( 13,934,844 )
Plus:
Accretion of carrying value to redemption value
$ 21,524,844
Class A common stock subject to possible redemption
$ 253,000,000
Warrant
Liabilities
The
Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates
all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain
features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC
815”). The Company accounts for warrants in accordance with the guidance in ASC 480 and ASC 815, Derivatives and Hedging (“ASC
815”) and determined that the warrants do not meet the criteria for equity treatment thereunder. The assessment considers whether
the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and
whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed
to the Company’s own common stock, among other conditions for equity classification. This assessment, which requires the use of
professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants
are outstanding.
Accordingly,
the Company recognizes the 8,433,333 Public Warrants and 4,706,667 Private Placement Warrants as liabilities at fair value and
adjusts the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet
date until exercised, and any change in fair value is recognized in the Company’s statement of operations. The Public Warrants
are valued by the closing price of the observable market quote in an active market. The Private
Placement Warrants are valued using an observable market quote for a similar asset in an active market.
See Notes 10 and 11.
Income
Taxes
The
Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax
assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement
carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured
using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered
or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included
the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be
realized. As of September 30, 2021, the Company had deferred tax assets of which had a full valuation allowance recorded against them.
The Company’s deferred tax assets were deemed to be de minimis as of December 31, 2020.
The
Company’s current taxable income primarily consists of interest earned on the Trust Account. The Company’s general and administrative
costs are generally considered start-up costs and are not currently deductible. During the three and nine months ended September 30,
2021, the Company recorded no income tax expense. The Company’s effective tax rate for three and nine months ended September 30,
2021 was approximately 0 %, which differs from the expected income tax rate due to the start-up costs (discussed above), the change in
value of warrant liabilities, and the transaction costs allocated to the warrant liabilities which are not currently deductible.
12
ROSECLIFF
ACQUISITION CORP I
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2021
(Unaudited)
ASC
740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions
taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be
sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits
as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30,
2021 and December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments,
accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since
inception.
Net
income (Loss) per Common Share
The
Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. The Company
applies the two-class method in calculating earnings per share. Net income (loss) per common share is calculated by dividing the net
income (loss) by the weighted average shares of common stock outstanding for the respective period. Accretion associated with the
redeemable shares of Class A common stocks is excluded from earnings per share as the redemption value approximates fair
value.
The
calculation of diluted income (loss) per share does not consider the effect of the warrants issued in connection with the
(i) Initial Public Offering and (ii) the private placement since the exercise of the warrants is contingent upon the
occurrence of future events. The warrants are exercisable to purchase 13,140,000 shares of Class A common stock in the
aggregate. As of September 30, 2021, the Company did not have any dilutive securities or other contracts that could potentially
be exercised or converted into shares of common stock and then share in the earnings of the Company. As a result, diluted net loss
per share of common stock is the same as basic net loss per share of common stock for the periods presented.
The
following table reflects the calculation of basic and diluted net loss per share of common stock (in dollars, except per share
amounts):
Three Months Ended
September 30, 2021
Nine Months Ended
September 30, 2021
Class A
Class B
Class A
Class B
Basic and diluted net loss per share of common
stock
Numerator:
Allocation of net loss, as adjusted
$ 1,781,736
$ 445,434
$ 1,964,042
$ 582,096
Denominator:
Basic and diluted weighted average shares outstanding
25,300,000
6,325,000
20,851,648
6,179,945
Basic and diluted net loss per share of common stock
$ 0.07
$ 0.07
$ 0.09
$ 0.09
Concentration
of Credit Risk
Financial
instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution,
which, at times may exceed the Federal Depository Insurance Corporation coverage limit of $ 250,000 . The Company has not experienced losses
on these accounts and management believes the Company is not exposed to significant risks on such account.
Fair
Value of Financial Instruments
The
fair value of the Company’s assets and liabilities which qualify as financial instruments under ASC Topic 820, “Fair Value
Measurement,” approximate the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their
short-term nature, other than the warrant liabilities (see Note 9).
13
ROSECLIFF
ACQUISITION CORP I
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2021
(Unaudited)
Fair
Value Measurements
Fair
value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction
between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs
used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets
or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:
●
Level
1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
●
Level
2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted
prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active;
and
●
Level
3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions,
such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
In
some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In
those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input
that is significant to the fair value measurement.
Derivative
Financial Instruments
The
Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded
derivatives in accordance with ASC Topic 815, “Derivatives and Hedging.” For derivative financial instruments that are accounted
for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each
reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments,
including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period.
Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion
of the instrument could be required within 12 months of the balance sheet date.
Recent
Accounting Pronouncements
In
August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06,
Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s
Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates
the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies
the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard
also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s
own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for
all convertible instruments. ASU 2020-06 is effective January 1, 2024 and should be applied on a full or modified retrospective basis,
with early adoption permitted beginning on January 1, 2021. The adoption of ASU 2020-06 will have no impact on the Company’s financial
position, results of operations or cash flows.
Management
does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a
material effect on the Company’s condensed financial statements.
14
ROSECLIFF
ACQUISITION CORP I
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2021
(Unaudited)
NOTE
4. INITIAL PUBLIC OFFERING
Pursuant
to the Initial Public Offering, the Company sold 25,300,000 Units, which includes a full exercise by the underwriter of its overallotment
option in the amount of 3,300,000 Units, at a price of $ 10.00 per Unit. Each Unit consists of one share of Class A common stock
and one-third of one redeemable warrant (each, a “Public Warrant”). Each whole Public Warrant entitles the holder to purchase
one share of Class A common stock at a price of $ 11.50 per share, subject to adjustment (see Note 9).
NOTE
5. PRIVATE PLACEMENT
Simultaneously
with the closing of the Initial Public Offering, the Sponsor has purchased an aggregate of 4,706,667 Private Placement Warrants at a
price of $ 1.50 per Private Placement Warrant ($ 7,060,000 in the aggregate) from the Company in a private placement. Each whole Private
Placement Warrant is exercisable to purchase one share of Class A common stock at a price of $ 11.50 per share, subject to adjustment
(see Note 9). A portion of the proceeds from the sale of the Private Placement Warrants were added to the net proceeds from the Initial
Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the
proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public
Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless.
NOTE
6. RELATED PARTY TRANSACTIONS
Founder
Shares
During
the period ended December 31, 2020, the Sponsor paid $ 25,000 to cover certain of the Company’s offering costs in exchange for 5,750,000
shares of the Company’s Class B common stock (the “Founder Shares”). On February 11, 2021, the Company effected
a 1:1.1 stock split of its Class B common stock, resulting in an aggregate of 6,325,000 shares outstanding. All share and per-share amounts
have been retroactively restated to reflect the stock split. The Founder Shares included an aggregate of up to 825,000 shares subject
to forfeiture to the extent that the underwriters’ over-allotment was not exercised in full or in part, so that the number of Founder
Shares would equal, on an as-converted basis, approximately 20 % of the Company’s issued and outstanding common stock upon the consummation
of the Initial Public Offering. As a result of the underwriter’s election to fully exercise its over-allotment option, no Founder
Shares are currently subject to forfeiture.
The
Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur
of: (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the
last reported sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations,
reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days
after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange, reorganization
or other similar transaction that results in all of the Public Stockholders having the right to exchange their shares of common stock
for cash, securities or other property.
15
ROSECLIFF
ACQUISITION CORP I
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2021
(Unaudited)
Amount
Due to Sponsor
At
September 30, 2021 the Company had advances owed to the Sponsor in the amount of $ 16,152 . At December 31, 2020, there were no advances
owed to the Sponsor.
Administrative
Services Agreement
Commencing
on February 11, 2021 through the earlier of the Company’s consummation of a Business Combination and its liquidation, the Company
agreed to pay the Sponsor a total of $ 10,000 per month for office space, support and administrative services. For the three and nine
months ended September 30, 2021, the Company accrued $ 30,000 and $ 80,000 in fees for these services, respectively, of which
such amount is included in accrued expenses in the accompanying condensed balance sheets.
Related
Party Loans
In
order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor or an
affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds
as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the
Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be
repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use
a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would
be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been
determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation
of a Business Combination, without interest, or, at the lender’s discretion, up to $ 1,500,000 of such Working Capital Loans may
be convertible into warrants of the post-Business Combination entity at a price of $ 1.50 per warrant. The warrants would be identical
to the Private Placement Warrants. As of September 30, 2021 and December 31, 2020, there were no amounts outstanding under the Working
Capital Loans.
16
ROSECLIFF
ACQUISITION CORP I
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2021
(Unaudited)
NOTE
7. COMMITMENTS
Risks
and Uncertainties
Management
continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could
have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific
impact is not readily determinable as of the date of these condensed financial statements. The condensed financial statements do not
include any adjustments that might result from the outcome of this uncertainty.
Registration
Rights
Pursuant
to a registration rights agreement entered into on February 11, 2021, the holders of the Founder Shares, Private Placement Warrants and
warrants that may be issued upon conversion of Working Capital Loans (and any shares of Class A common stock issuable upon the exercise
of the Private Placement Warrants or warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the
Founder Shares) will be entitled to registration rights requiring the Company to register such securities for resale (in the case of
the Founder Shares, only after conversion to shares of Class A common stock). The holders of these securities will be entitled to
make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders
have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion
of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the
Securities Act. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration
or cause any registration statement to become effective until termination of the applicable lock-up period. The registration rights agreement
does not contain liquidated damages or other cash settlement provisions resulting from delays in registering our securities. The Company
will bear the expenses incurred in connection with the filing of any such registration statements.
Underwriting
Agreement
The
underwriters are entitled to a deferred fee of $ 0.35 per Unit, or $ 8,855,000 in the aggregate. The deferred fee will become payable to
the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject
to the terms of the underwriting agreement.
NOTE
8. STOCKHOLDERS’ EQUITY
Preferred
Stock — The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $ 0.0001 per share with
such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors.
At September 30, 2021 and December 31, 2020, there were no shares of preferred stock issued or outstanding.
Class A
Common Stock — The Company is authorized to issue 80,000,000 shares of Class A common stock with a par value of $ 0.0001
per share. Holders of Class A common stock are entitled to one vote for each share. At September 30, 2021, there were 25,300,000
shares of Class A common stock issued and outstanding, which are presented as temporary equity. At December 31, 2020, there were no shares
of Class A common stock issued or outstanding.
Class B
Common Stock — The Company is authorized to issue 20,000,000 shares of Class B common stock with a par value of $ 0.0001
per share. Holders of Class B common stock are entitled to one vote for each share. At September 30, 2021 and December 31, 2020,
there were 6,325,000 shares of Class B common stock issued and outstanding.
17
ROSECLIFF
ACQUISITION CORP I
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2021
(Unaudited)
Holders
of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to
a vote of our shareholders, except as otherwise required by law.
The
shares of Class B common stock will automatically convert into Class A common stock at the time of a Business Combination,
or earlier at the option of the holder, on a one-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations,
recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional shares of Class A
common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts issued in the Initial Public Offering
and related to the closing of a Business Combination, the ratio at which the shares of Class B common stock will convert into shares
of Class A common stock will be adjusted (unless the holders of a majority of the issued and outstanding shares of Class B
common stock agree to waive such anti-dilution adjustment with respect to any such issuance or deemed issuance) so that the number of
shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate,
on an as-converted basis, 20% of the sum of all shares of common stock issued and outstanding upon the completion of the Initial Public
Offering plus all shares of Class A common stock and equity-linked securities issued or deemed issued in connection with the initial
Business Combination, excluding any shares or equity-linked securities issued, or to be issued, to any seller in the initial Business
Combination.
NOTE
9. WARRANTS
As
of September 30, 2021, there were 8,433,333 Public Warrants outstanding. As of December 31, 2020, there were no Public Warrants outstanding.
Public Warrants may only be exercised in whole and only for a whole number of shares. The Public Warrants will become exercisable on the later of (a) 30 days after the
completion of a Business Combination and (b) 12 months from the closing of the Initial Public Offering. The Public Warrants will expire
five years after the completion of a Business Combination or earlier upon redemption or liquidation.
The
Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a warrant and will have
no obligation to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares
of Class A common stock underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company
satisfying its obligations with respect to registration, or a valid exemption from registration is available. No warrant will be exercisable
for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants,
unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising
holder, or an exemption is available.
The
Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of a Business Combination,
the Company will use its commercially reasonable efforts to file a registration statement covering the issuance, under the Securities
Act, of the Class A common stock issuable upon exercise of the warrants, and the Company will use its commercially reasonable efforts
to cause the same to become effective within 60 business days after the closing of a Business Combination and to maintain the effectiveness
of such registration statement, and a current prospectus relating thereto, until the expiration of the warrants in accordance with the
provisions of the warrant agreement.
Notwithstanding
the above, if the shares of Class A common stock are, at the time of any exercise of a warrant, not listed on a national securities
exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act,
the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis”
in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required
to file or maintain in effect a registration statement, but will use its commercially reasonable efforts to register or qualify the shares
under applicable blue sky laws to the extent an exemption is not available.
18
ROSECLIFF
ACQUISITION CORP I
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2021
(Unaudited)
Redemption
of Warrants When the Price per share of Class A common stock Equals or Exceeds $18.00 — Once the warrants become exercisable,
the Company may redeem the warrants (except as described herein with respect to the Private Placement Warrants):
●
in
whole and not in part;
●
at
a price of $0.01 per warrant;
●
upon
not less than 30 days’ prior written notice of redemption to each warrant holder; and
● if, and only if, the last reported sale price of the Class A common stock for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders (the “Reference Value”) equals or exceeds $18.00 per share (as adjusted).
If
and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register
or qualify the underlying securities for sale under all applicable state securities laws.
Redemption
of Warrants When the Price per share of Class A common stock Equals or Exceeds $10.00 — Once the warrants become exercisable,
the Company may redeem the outstanding warrants:
●
in
whole and not in part;
●
at
$0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption, provided that holders will be able to
exercise their warrants on a cashless basis prior to redemption and receive that number of shares based on the redemption date and
the fair market value of the shares of Class A common stock;
●
if,
and only if, the Reference Value equals or exceeds $10.00 per share (as adjusted); and
● if the Reference Value is less than $18.00 per share (as adjusted), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above.
The
exercise price and number of shares of Class A common stock issuable upon exercise of the Public Warrants may be adjusted in
certain circumstances including in the event of a share dividend, extraordinary dividend or recapitalization, reorganization, merger
or consolidation. However, except as described below, the Public Warrants will not be adjusted for issuances of Class A common
stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the Public
Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the
funds held in the Trust Account, holders of Public Warrants will not receive any of such funds with respect to their Public
Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to
such Public Warrants. Accordingly, the Public Warrants may expire worthless.
In
addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising
purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.20
per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company’s
board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares
held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate
gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding
of the Company’s initial Business Combination on the date of the consummation of such initial Business Combination (net of redemptions),
and (z) the volume weighted average trading price of the Company’s common stock during the 20 trading day period starting
on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market
Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115%
of the higher of the Market Value and the Newly Issued Price, the $18.00 and $10.00 per share redemption trigger price described above
will be adjusted (to the nearest cent) to be equal to 180% and 100%, respectively, of the higher of the Market Value and the Newly Issued
Price.
At
September 30, 2021, there were 4,706,667 Private Placement Warrants outstanding. As of December 31, 2020 there were no Private Placement
Warrants outstanding. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public
Offering, except that the Private Placement Warrants and the Class A common stock issuable upon the exercise of the Private Placement
Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to
certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and be non-redeemable,
except as described above, so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement
Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be
redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.
19
ROSECLIFF
ACQUISITION CORP I
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2021
(Unaudited)
NOTE
10. FAIR VALUE MEASUREMENTS
The
fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would
have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction
between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company
seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable
inputs (internal assumptions about how market participants would price assets and liabilities). The fair value hierarchy (see Note 3)
is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and
liabilities.
At
September 30, 2021, assets held in the Trust Account were comprised of $ 253,023,010 in a U.S. Fixed income securities fund. During the
three and nine months ended September 30, 2021, the Company did not withdraw any interest income from the Trust Account.
The
following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring
basis at September 30, 2021 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair
value.
Description
Level
September 30,
2021
Assets:
Investments held in Trust Account – U.S. Treasury Fund
1
$ 253,023,010
Description
Level
September 30,
2021
Liabilities:
Warrant Liability – Public Warrants
1
$ 4,638,333
Warrant Liability – Private Placement Warrants
2
$ 2,588,667
The
Warrants were accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on our accompanying
September 30, 2021 condensed balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis,
with changes in fair value presented within change in fair value of warrant liabilities in the condensed statement of operations.
20
ROSECLIFF
ACQUISITION CORP I
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2021
(Unaudited)
The Company initially valued its Private
Placement Warrants utilizing a lattice model, specifically a binomial lattice model incorporating the Cox-Ross-Rubenstein
methodology and subsequently valued the Private Placement Warrants through June 30, 2021, with changes in fair value recognized in
the statement of operations. The estimated fair value of the warrant liabilities was determined using Level 3 inputs. Inherent in a
binomial options pricing model are assumptions related to expected share-price volatility, expected life, risk-free interest rate
and dividend yield. The Company estimates the volatility of its shares of common stock based on historical volatility that matches
the expected remaining life of the Private Placement Warrants. The risk-free interest rate was based on the U.S. Treasury zero-coupon
yield curve on the grant date for a maturity similar to the expected remaining life of the Private Placement Warrants. The expected
life of the warrants were assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical
rate, which the Company anticipates to remain at zero .
The measurement of the Public Warrants after
the detachment of the Public Warrants from the Units is classified as Level 1 due to the use of an observable market quote in an active
market. For periods subsequent to the detachment of the Public Warrants from the Units, the closing price of the Public Warrant was used
as the fair value for the Warrants as of each relevant date. At September 30, 2021 the Private Placement Warrants transferred to Level
2 due to the use of an observable market quote for a similar asset in an active market.
The
following table presents the changes in the fair value of the warrant liabilities (Level 3 measurements):
Private
Placement
Public
Warrant
Liabilities
Fair value as of January 1, 2021
$ —
$ —
$ —
Initial measurement on February 17, 2021
4,236,000
7,590,000
11,826,000
Change in fair value
( 1,364,933 )
( 2,445,667 )
( 3,810,600 )
Fair value as of March 31, 2021
$ 2,871,067
$ 5,144,333
$ 8,015,400
Change in fair value
941,333
1,686,667
2,628,000
Transfer to Level 1
—
( 6,831,000 )
( 6,831,000 )
Fair value as of June 30, 2021
3,812,400
—
3,812,400
Change in fair value
( 1,223,733 )
—
( 1,223,733 )
Transfer to Level 2
( 2,588,667 )
—
( 2,588,667 )
Fair value as of September 30, 2021
$ —
—
—
Transfers
to/from Levels 1, 2 and 3 are recognized at the end of the reporting period in which a change in valuation technique or methodology
occurs. The estimated fair value of the Public Warrants previously transferred from a Level 3 measurement to a Level 1 fair value
measurement during the six months ended June 30, 2021 was $ 6,831,000 . The estimated fair value of the Private Placement Warrants transferred from a Level 3 measurement
to a Level 2 fair value measurement during the nine months ended September 30, 2021 was $ 2,588,667 .
21
ROSECLIFF
ACQUISITION CORP I
NOTES TO CONDENSED FINANCIAL STATEMENTS
SEPTEMBER 30, 2021
(Unaudited)
NOTE
11. SUBSEQUENT EVENTS
On November 9, 2021, the Company (“Rosecliff”),
GT Gettaxi Listco, a Cayman Islands corporation (“Pubco”), GT Gettaxi Limited, a Cyprus corporation (“GT Gettaxi”),
GT Gettaxi SPV, a Cayman Islands exempted company (“SPV Holdco”), GT Gettaxi Merger Sub 1, a Cayman Islands exempted company
(“Merger Sub I”), Gett Merger Sub, Inc., a Delaware corporation (“Merger Sub I”), and Dooboo Holding Limited,
a Cyprus corporation (“Dooboo”), entered into a Business Combination Agreement (the “Business Combination Agreement”),
pursuant to which, among other things, Rosecliff agreed to combine with the Company in a business combination. Each of Pubco, SPV Holdco,
Merger Sub I and Merger Sub II is a newly formed entity that was formed for the sole purpose of entering into and consummating the transactions
set forth in the Business Combination Agreement.
At the SPV Merger Effective Time, Pubco will issue
to the shareholders of GT Gettaxi an aggregate number of Pubco Ordinary Shares equal to the quotient of $ 821 million (“SPV Value”)
divided by $ 10.00 per share (the “SPV Share Consideration”). A portion of the SPV Share Consideration shall be issued at the
closing of the business combination, with the remaining portion of the SPV Share Consideration to be issued upon the earliest to occur
of the two year anniversary of the Closing Date, the date on which the product of the SPV Share Consideration and the Pubco VWAP is equal
to or greater than $ 3.1 billion for a period of at least twenty consecutive trading days and immediately prior to the consummation of
a Pubco Sale. Promptly after the Reorganization, each issued and outstanding option in the Company or its subsidiaries, whether vested
or unvested, will automatically be converted into and exchanged for an SPV Holdco Option. Subject to certain limited exceptions, at the
SPV Merger Effective Time, each issued and outstanding SPV Holdco Option, whether vested or unvested, will automatically be converted
into and exchanged for an option to purchase Pubco Ordinary Shares.
At the SPAC Merger Effective Time, each issued and outstanding share
of Class A common stock of Rosecliff (“Rosecliff Common Stock”) will automatically be converted into and exchanged for the
right to receive one Pubco Ordinary Share, each issued and outstanding public warrant of Rosecliff will automatically be converted into
and exchanged for the right to receive one public warrant of Pubco (“Pubco Public Warrants”), each issued and outstanding
private warrant of Rosecliff will automatically be converted into and exchanged for the right to receive one private warrant of Pubco.
Each of the Pubco Public Warrants and Pubco Private Warrants will have substantially the same terms and conditions as are in effect with
respect to the Rosecliff Public Warrants and Rosecliff Private Warrants immediately prior to the SPAC Merger Effective Time.
In connection with the Proposed Transactions and
concurrently with the execution of the Business Combination Agreement, Pubco and Rosecliff entered into subscription agreements with Sponsor
and certain GT Gettaxi shareholders, pursuant to which, among other things, each Initial Subscriber has agreed to subscribe for and purchase
on the Closing Date, and Pubco has agreed to issue and sell to each such Initial Subscriber on the Closing Date, the number of Pubco Ordinary
Shares set forth in the applicable Initial Subscription Agreement in exchange for the purchase price set forth therein (the aggregate
purchase price under all Initial Subscription Agreements). The aggregate number of Pubco Ordinary Shares subscribed for by the Initial
Subscribers under the Subscription Agreements is three million for aggregate consideration of $ 30 million.
The
Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the condensed
financial statements were issued. Based upon this review, other than disclosed above, the Company did not identify any subsequent
events, that would have required adjustment or disclosure in the condensed financial statements.
22
Item
2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
References
in this report (the “Quarterly Report”) to “we,” “us” or the “Company” refer to Rosecliff
Acquisition Corp I. References to our “management” or our “management team” refer to our officers and directors,
and references to the “Sponsor” refer to Rosecliff Acquisition Sponsor I LLC. The following discussion and analysis of the
Company’s financial condition and results of operations should be read in conjunction with the financial statements and the notes
thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes
forward-looking statements that involve risks and uncertainties.
Special
Note Regarding Forward-Looking Statements
This
Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Exchange Act that are not historical facts and involve risks and uncertainties that could cause actual results to
differ materially from those expected and projected. All statements, other than statements of historical fact included in this Form 10-Q
including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results
of Operations” regarding the completion of the Business Combination (as defined below), the Company’s financial position,
business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,”
“believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and
similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future
events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors
could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking
statements, including that the conditions of the Business Combination are not satisfied. For information identifying important factors
that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk
Factors section of the Company’s final prospectus for its Initial Public Offering filed with the U.S. Securities and Exchange Commission
(the “SEC”). The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov.
Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any
forward-looking statements whether as a result of new information, future events or otherwise.
This Management’s Discussion and Analysis
of Financial Condition and Results of Operations has been amended and restated to give effect to the restatement of our financial statements
as of February 17, 2021, March 31, 2021 and June 30, 2021 discussed in Note 2 to the condensed financial statements included in Item
1. Management identified errors made in its historical financial statements where, at the closing of our Initial Public Offering, we
improperly valued our Class A common stock subject to possible redemption. We previously determined the Class A common stock subject
to possible redemption to be equal to the redemption value of $10.00 per share of Class A common stock while also taking into consideration
that a redemption cannot result in net tangible assets being less than $5,000,001. Management determined that the Class A common stock
issued during the Initial Public Offering can be redeemed or become redeemable subject to the occurrence of future events considered
outside of the Company’s control. Therefore, management concluded that the carrying value should include all Class A common stock
subject to possible redemption, resulting in the Class A common stock subject to possible redemption being classified as temporary equity
in its entirety. As a result, management has noted a classification error related to temporary equity and permanent equity. This resulted
in a restatement to the initial carrying value of the Class A common stock subject to possible redemption with the offset recorded to
additional paid-in capital (to the extent available), accumulated deficit and Class A common stock.
Overview
We
are a blank check company formed under the laws of the State of Delaware on November 17, 2020 for the purpose of effecting a merger,
capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
We intend to effectuate our Business Combination using cash from the proceeds of the Initial Public Offering and the sale of the Private
Placement Warrant, our capital stock, debt or a combination of cash, stock and debt.
We
expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete
a Business Combination will be successful.
Results
of Operations
We
have neither engaged in any operations nor generated any revenues to date. Our only activities for the three and nine months ended September
30, 2021 were organizational activities, those necessary to prepare for the Initial Public Offering, described below, and identifying
a target company for a Business Combination. We do not expect to generate any operating revenues until after the completion of our Business
Combination. We generate non-operating income in the form of interest income on marketable securities held in the Trust Account. We incur
expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due
diligence expenses.
For
the three months ended September 30, 2021, we had a net income of $2,227,170, which consists of change in fair value of warrant liabilities
of $3,416,400 and interest income on marketable securities held in the Trust Account of $3,506, offset by operating costs of $1,192,736.
For
the nine months ended September 30, 2021, we had a net income of $2,546,138, which consists of change in fair value of warrant liabilities
of $4,599,000 and interest income on marketable securities held in the Trust Account of $23,010, and transaction costs allocated to warrant
liabilities of $438,283, offset by operating costs of $1,637,589.
23
Liquidity
and Capital Resources
On
February 17, 2021, we consummated the Initial Public Offering of 25,300,000 Units at $10.00 per Unit, generating gross proceeds of $253,000,000
which is described in Note 4. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 4,706,667
Private Placement Warrant at a price of $1.50 per Private Placement Warrant in a private placement to the Sponsor, generating gross proceeds
of $7,060,000, which is described in Note 5.
For
the nine months ended September 30, 2021, cash used in operating activities was $731,251. Net income of $2,546,138 was affected by transaction
costs associated with Initial Public Offering of $438,283, change in fair value of warrant liabilities of $4,599,000 and interest income
on marketable securities held in the Trust Account of $23,010. Changes in operating assets and liabilities provided $906,338 of cash
for operating activities.
As
of September 30, 2021, we had U.S. Treasury Funds held in the Trust Account of $253,023,010 consisting of fixed income securities.
Interest income on the balance in the Trust Account may be used by us to pay taxes. We intend to use substantially all of the funds
held in the Trust Account, including any amounts representing interest earned on the Trust Account (less income taxes payable), to
complete our Business Combination. To the extent that our capital stock or debt is used, in whole or in part, as consideration to
complete our Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the
operations of the target business or businesses, make other acquisitions and pursue our growth strategies.
As
of September 30, 2021, we had cash of $863,774. We intend to use the funds held outside the Trust Account primarily to identify and evaluate
target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar
locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of
prospective target businesses, and structure, negotiate and complete a Business Combination.
In
order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor, or certain
of our officers and directors or their affiliates may, but are not obligated to, loan us funds as may be required. If we complete a Business
Combination, we would repay such loaned amounts. In the event that a Business Combination does not close, we may use a portion of the
working capital held outside the Trust Account to repay such loaned amounts but no proceeds from our Trust Account would be used for
such repayment. Up to $1,500,000 of such loans may be convertible into units at a price of $10.00 per unit, at the option of the lender.
The units would be identical to the Private Placement Warrants.
We
do not believe we will need to raise additional funds in order to meet the expenditures required for operating our business. However,
if our estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating a Business Combination
are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our Business
Combination. Moreover, we may need to obtain additional financing either to complete our Business Combination or because we become obligated
to redeem a significant number of our Public Shares upon consummation of our Business Combination, in which case we may issue additional
securities or incur debt in connection with such Business Combination.
Based on above, management evaluated the
Company’s liquidity and financial condition and has determined that sufficient capital and access to capital exists to sustain
operations for at least one year from the date the financial statements were issued.
Off-Balance
Sheet Arrangements
We
have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of September 30, 2021. We do
not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as
variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have
not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments
of other entities, or purchased any non-financial assets.
Contractual
obligations
We
do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement
to pay an affiliate of one of our executive officers a monthly fee of $10,000 for office space, support and administrative services.
We began incurring these fees on February 11, 2021 and will continue to incur these fees monthly until the earlier of the completion
of the Business Combination and our liquidation.
The
underwriters are entitled to a deferred fee of $0.35 per Unit, or $8,855,000 in the aggregate. The deferred fee will become payable to
the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject
to the terms of the underwriting agreement.
24
Critical
Accounting Policies
The
preparation of condensed financial statements and related disclosures in conformity with accounting principles generally accepted in
the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities,
disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported.
Actual results could materially differ from those estimates. We have identified the following critical accounting policies:
Warrant
Liabilities
We
do not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. We evaluate all of our financial
instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify
as embedded derivatives, pursuant to ASC 480 and ASC 815. The Company accounts for warrants in accordance with the guidance in ASC 480
and ASC 815, Derivatives and Hedging (“ASC 815”) and determined that the Warrants do not meet the criteria for equity treatment
thereunder. The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition
of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including
whether the warrants are indexed to the Company’s own common stock, among other conditions for equity classification. This assessment,
which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period
end date while the warrants are outstanding.
Accordingly,
the Company recognizes the 8,433,333 Public Warrants and 4,706,667 Private Placement Warrants as liabilities at fair value and adjusts
the instruments to fair value at each reporting period. The liabilities are subject to re-measurement at each balance sheet date until
exercised, and any change in fair value is recognized in the Company’s statement of operations. The estimated fair value of the
Public Warrants were measured at fair value using a binomial lattice model incorporating the Cox-Ross-Rubenstein methodology.
The measurement of the Public Warrants after the
separation of the Public Warrants from the Units is classified as Level 1 due to the use of an observable market quote in an active market.
For periods subsequent to the separation of the Public Warrants from the Units, the closing price of the Public Warrant was used as the
fair value for the warrants as of each relevant date. At September 30, 2021 the Private Placement Warrants transferred to Level 2 due
to the use of an observable market quote for a similar asset in an active market. See Notes 10 and 11.
Class
A Common Stock Subject to Possible Redemption
We
account for our Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480. Shares of Class
A common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable
common stock (including common stock that feature redemption rights that is either within the control of the holder or subject to redemption
upon the occurrence of uncertain events not solely within our control) is classified as temporary equity. At all other times, common
stock is classified as stockholders’ equity. Our Class A common stock features certain redemption rights that are considered to
be outside of our control and subject to occurrence of uncertain future events. Accordingly, 25,300,000 shares of Class A common
stock subject to possible redemption are presented as temporary equity, outside of the stockholders’ equity section of our balance
sheets.
Net
Income (Loss) Per Common Share
The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company applies
the two-class method in calculating earnings per share. Net income (loss) per common share is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding
for the respective period. Accretion associated with the redeemable shares of Class A common
stocks is excluded from earnings per share as the redemption value approximates fair value.
Recent
Accounting Standards
In
August 2020, the FASB issued Accounting Standards Update (“ASU”) 2020-06, Debt — Debt with Conversion and Other Options
(Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”)
to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial
conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining
to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible
debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings
per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective
January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1,
2021. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations
or cash flows.
Management does not believe that any other recently issued, but
not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s condensed
financial statements.
Business Combination
On November 9, 2021, the Company, GT Gettaxi
Listco, a Cayman Islands corporation, GT Gettaxi Limited, a Cyprus corporation , GT Gettaxi SPV, a Cayman Islands exempted company, GT
Gettaxi Merger Sub 1, a Cayman Islands exempted company, Gett Merger Sub, Inc., a Delaware corporation, and Dooboo Holding Limited, a
Cyprus corporation, entered into a Business Combination Agreement. Completion of the transaction is subject to approval of the Company’s
stockholders and the satisfaction or waiver of certain other customary closing conditions. In connection with the Business Combination,
the Company entered into subscription agreements dated as of November 9, 2021, with certain institutional and accredited investors, pursuant
to which, among other things, the Company agreed to issue and sell, in a private placement, concurrent with the consummation of the Business
Combination, an aggregate of 3,000,000 shares of common stock for $10.00 per share for an aggregate cash amount of $30,000,000.
25
Item
3. Quantitative and Qualitative Disclosures About Market Risk
Not
required for smaller reporting companies.
Item
4. Controls and Procedures
Disclosure controls and procedures are designed
to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported
within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our
management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate
to allow timely decisions regarding required disclosure.
Evaluation of Disclosure Controls and Procedures
As required by Rules 13a-15 and 15d-15 under
the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the
design and operation of our disclosure controls and procedures as of September 30, 2021. Based on this evaluation, our Chief
Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were not effective, solely
due to the material weakness in our internal control over financial reporting related to the Company’s accounting for complex financial instruments. As a result, we performed
additional analysis as deemed necessary to ensure that our financial statements were prepared in accordance with U.S. generally
accepted accounting principles. Accordingly, management believes that the financial statements included in this Form 10-Q
present fairly in all material respects our financial position, results of operations and cash flows for the period presented.
Changes in Internal Control Over Financial
Reporting
During the most recent fiscal quarter ended September
30, 2021, we made changes in our internal control processes over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f)
of the Exchange Act), other than the circumstances described above, to issues that have materially affected, or, in anticipation, to reasonably
likely to materially affect our internal control over financial reporting. Management implemented steps to improve our internal control
over financial reporting. Specifically, we expanded and improved our review process for complex securities and related accounting standards.
The foregoing actions, were completed as of September 30, 2021.
In light of the material weakness, we enhanced
our processes to identify and appropriately apply applicable accounting requirements to better evaluate and understand the nuances of
the complex accounting standards that apply to our financial statements, including providing enhanced access to accounting literature,
research materials and documents and increased communication among our personnel and third-party professionals with whom we consult regarding
complex accounting applications. We will continue to evaluate whether additional measures should be implemented with respect to such material
weakness. As we continue to evaluate and improve our financial reporting process, we may take additional actions to modify certain of
the measures described above. We cannot assure you that the measures we have taken to date, or any measures we may take in the future,
will be sufficient to avoid potential future material weaknesses.
26
PART
II - OTHER INFORMATION
Item
1. Legal Proceedings
None.
Item
1A. Risk Factors
Factors
that could cause our actual results to differ materially from those in this report include the risk factors described in our final prospectus
for its Initial Public Offering filed with the SEC. As of the date of this Report, there have been no material changes to the risk factors
disclosed in our final prospectus for our Initial Public Offering filed with the SEC, other than as described below. We may disclose
changes to such factors or disclose additional factors from time to time in our future filings with the SEC.
Our
warrants are accounted for as liabilities and the changes in value of our warrants could have a material effect on our financial results.
On
April 12, 2021, the staff of the SEC issued a public statement regarding the accounting and reporting considerations for warrants issued
by special purpose acquisition companies entitled “Staff Statement on Accounting and Reporting Considerations for Warrants Issued
by Special Purpose Acquisition Companies (‘SPACs’)” (the “SEC Statement”). Specifically, the SEC Statement
focused on certain settlement terms and provisions related to certain tender offers following a business combination, which terms are
similar to those contained in the warrant agreement governing our Warrants. As a result of the SEC Statement, we reevaluated the accounting
treatment of our 8,433,333 Public Warrants and 4,706,667 Private Placement Warrants, and determined to classify the Warrants as derivative
liabilities measured at fair value, with changes in fair value each period reported in earnings.
As
a result, included on our condensed balance sheet as of September 30, 2021 contained elsewhere in this Quarterly Report are derivative
liabilities related to embedded features contained within our warrants. Accounting Standards Codification 815, Derivatives and Hedging,
provides for the remeasurement of the fair value of such derivatives at each balance sheet date, with a resulting non-cash gain or loss
related to the change in the fair value being recognized in earnings in the statement of operations. As a result of the recurring fair
value measurement, our consolidated financial statements and results of operations may fluctuate quarterly, based on factors, which are
outside of our control. Due to the recurring fair value measurement, we expect that we will recognize non-cash gains or losses on our
Warrants each reporting period and that the amount of such gains or losses could be material. The impact of changes in fair value on
earnings may have an adverse effect on the market price of our securities.
We
have identified a material weakness in our internal control over financial reporting as of September 30, 2021. If we are unable to develop
and maintain an effective system of internal control over financial reporting, we may not be able to accurately report our financial
results in a timely manner, which may adversely affect investor confidence in us and materially and adversely affect our business and
operating results.
In connection with the preparation of the
Company’s financial statements as of September 30, 2021, the Company reevaluated the classification of the shares of its Class
A common stock subject to possible redemption. After consultation with the Company’s Audit Committee, the Company’s
management concluded that the previously issued audited balance sheet dated as of February 17, 2021, which was related to our
Initial Public Offering, and the unaudited interim financial statements included in our Quarterly Reports on Form 10-Q for the
quarterly periods ended March 31, 2021 and June 30, 2021, respectively, should be restated to report all Class A common stock
subject to possible redemption as temporary equity.
As described elsewhere in this Quarterly Report on Form 10-Q, we identified
a material weakness in our internal control over financial reporting related to the accounting for the Company’s Class A common
stock subject to possible redemption. A material weakness is a deficiency, or a combination of deficiencies, in internal control over
financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements
will not be prevented, or detected and corrected on a timely basis. As a result of this material weakness, and the material weakness disclosed
in our Quarterly Report on Form 10-Q, as filed with the SEC on August 16, 2021, our management has concluded that our internal control
over financial reporting was not effective as of September 30, 2021.
Effective
internal controls are necessary for us to provide reliable financial reports and prevent fraud. We continue to evaluate steps to remediate
the material weakness. These remediation measures may be time consuming and costly and there is no assurance that these initiatives will
ultimately have the intended effects.
If
we identify any new material weaknesses in the future, any such newly identified material weakness could limit our ability to prevent
or detect a misstatement of our accounts or disclosures that could result in a material misstatement of our annual or interim financial
statements. In such case, we may be unable to maintain compliance with securities law requirements regarding timely filing of periodic
reports in addition to applicable stock exchange listing requirements, investors may lose confidence in our financial reporting and our
stock price may decline as a result. We cannot assure you that the measures we have taken to date, or any measures we may take in the
future, will be sufficient to avoid potential future material weaknesses.
27
We
may face litigation and other risks as a result of the material weakness in our internal control over financial reporting.
As
a result of such material weakness, the change in accounting for the warrants, and other matters raised or that may in the future be
raised by the SEC, we face potential for litigation or other disputes which may include, among others, claims invoking the federal
and state securities laws, contractual claims or other claims arising from the material weaknesses in our internal control over
financial reporting and the preparation of our financial statements. As of the date of this Quarterly Report on Form 10-Q, we have
no knowledge of any such litigation or dispute. However, we can provide no assurance that such litigation or dispute will not arise
in the future. Any such litigation or dispute, whether successful or not, could have a material adverse effect on our business,
results of operations and financial condition or our ability to complete a business combination.
Item
2. Unregistered Sales of Equity Securities and Use of Proceeds.
On
February 17, 2021, we consummated the Initial Public Offering of 25,300,000 Units. The Units were sold at an offering price of $10.00
per unit, generating total gross proceeds of $253,000,000. The securities in the offering were registered under the Securities Act on
registration statement on Form S-1 (No. 333-252478). The Securities and Exchange Commission declared the registration statements effective
on February 11, 2021.
Simultaneous
with the consummation of the Initial Public Offering, the Sponsor consummated the private placement of an aggregate of 4,706,667 warrants
(the “Private Placement Warrants”) at a price of $1.50 per Private Placement Warrant, generating total proceeds of $7,060,000.
Each whole Private Warrant is exercisable to purchase one share of common stock at an exercise price of $11.50 per share. The issuance
was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.
The
Private Placement Warrants are identical to the warrants underlying the Units sold in the Initial Public Offering, except that the
Private Placement Warrants are not transferable, assignable or salable until after the completion of a Business Combination, subject
to certain limited exceptions.
Of
the gross proceeds received from the Initial Public Offering, the exercise of the over-allotment option and the Private Placement Warrant,
an aggregate of $253,000,000 was placed in the Trust Account.
We
paid a total of $5,060,000 in underwriting discounts and commissions and $457,127 for other costs and expenses related to the Initial
Public Offering.
For
a description of the use of the proceeds generated in our Initial Public Offering, see Part I, Item 2 of this Form 10-Q.
Item
3. Defaults Upon Senior Securities
None
Item
4. Mine Safety Disclosures
None
Item
5. Other Information
None
28
Item
6. Exhibits
The
following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.
No.
Description
of Exhibit
31.1*
Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*
Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1**
Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2* *
Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*
Inline
XBRL Instance Document.
101.SCH*
Inline
XBRL Taxonomy Extension Schema Document.
101.CAL*
Inline
XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF*
Inline
XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB*
Inline
XBRL Taxonomy Extension Label Linkbase Document.
101.PRE*
Inline
XBRL Taxonomy Extension Presentation Linkbase Document.
104
Cover
Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
*
Filed
herewith.
* *
Furnished
herewith.
29
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.
ROSECLIFF
ACQUISITION CORP I
Date:
November 22, 2021
By:
/s/
Michael P. Murphy
Name:
Michael
P. Murphy
Title:
Chief
Executive Officer
(Principal
Executive Officer)
Date:
November 22, 2021
By:
/s/
Kieran Goodwin
Name:
Kieran
Goodwin
Title:
Chief
Financial Officer
(Principal
Financial and Accounting Officer)
30
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.